GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cuorips 4894.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

6,460

+6.78%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥212.3m

FY2021FY2026

Net income

−¥1.02bn

FY2021FY2026

Free cash flow

−¥1.10bn

FY2021FY2026

Shareholders' equity

¥4.75bn

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue¥212.3m¥175.2m¥23.1m¥38.3m¥13.9m¥220,000
Gross profit¥45.9m¥91.6m−¥60.5m−¥57.6m−¥82.1m−¥73.8m
Research and development—¥334.1m¥209.8m¥648.5m¥112.8m¥72.6m
Operating income−¥1.08bn−¥590.3m−¥610.5m−¥450.4m−¥373.2m−¥295.1m
Net income−¥1.02bn−¥644.3m−¥632.2m−¥452.1m−¥375.3m−¥307.8m
Diluted earnings per share-123.84-78.18-78.90-57.35-49.81-37.28

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assets¥5.12bn¥5.74bn¥6.18bn¥3.59bn¥4.04bn¥4.36bn
Cash and short-term investments¥3.90bn¥4.79bn¥5.58bn¥2.94bn¥3.34bn¥3.54bn
Total liabilities¥353.8m¥211.9m¥201.0m¥133.8m¥149.4m¥142.0m
Shareholders' equity¥4.75bn¥5.53bn¥5.98bn¥3.45bn¥3.90bn¥4.22bn
Shares outstanding8m8m8m8m8m8m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations−¥1.06bn−¥812.6m−¥451.1m−¥401.6m−¥220.8m−¥282.8m
Capital spending−¥43.0m−¥80.2m−¥23.8m−¥10.6m−¥28.7m−¥668.2m
Free cash flow−¥1.10bn−¥892.8m−¥474.8m−¥412.2m−¥249.5m−¥951.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥1.6m¥5.1m¥14.5m¥107.4m¥85.3m¥148.4m¥18.9m¥7.7m
Gross profit−¥30.8m−¥18.9m−¥9.2m¥64.1m¥9.9m¥126.1m−¥4.1m−¥12.8m
Operating income−¥333.4m−¥309.9m−¥276.1m−¥298.8m−¥196.5m−¥25.5m−¥166.1m−¥203.4m
Net income−¥317.8m−¥290.5m−¥248.6m−¥282.9m−¥200.6m−¥32.5m−¥145.7m−¥273.5m
Diluted earnings per share-38.49-35.18-30.16-34.33-24.34-3.94-18.18-34.13
Total assets¥4.81bn¥5.12bn¥5.21bn¥5.45bn¥5.75bn¥5.74bn¥5.63bn¥5.76bn
Cash and short-term investments¥3.32bn¥3.90bn¥3.80bn¥4.07bn¥4.85bn¥4.79bn¥4.95bn¥4.79bn
Shareholders' equity¥4.44bn¥4.75bn¥5.01bn¥5.23bn¥5.42bn¥5.53bn¥5.44bn¥5.58bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue77.0%295.3%—
Operating income33.9%29.7%—
Net income31.3%27.1%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin35.5%4.3%-29.5%—
Operating margin-431.3%-608.7%-734.4%—
Net margin-430.1%-612.9%-741.7%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023
Price to earnings-52.9-77.1-58.4-40.5
Price to sales254.7283.7—477.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.